HIV/AIDS Immune Activation
Use of HAART and other factors increase oxidative damage
Published in Blood Weekly, April 14th, 2005
According to a recent report from the United States, "In a cross-sectional study involving subjects from the Reaching for Excellence in Adolescent Health cohort, we examined the associations between HIV status, disease severity, immune activation, and oxidative damage.
"Subjects (265 HIV-positive and 127 HIV-negative) were young (range: 14-23 years of age) and primarily female (75%) and black (67%). Many subjects, particularly female subjects, were overweight or obese. Relatively few HIV-positive subjects had advanced HIV disease (13%), and 54% were taking antiretroviral therapy...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-04-14)
More Articles from Blood Weekly
- Blood Cell Substitute
Liposomes encapsulating hemoglobin evaluated as a red blood cell substitute - Leukapheresis
SC mobilization influences CD34+ cell collection efficiency of leukapheresis - Stem Cell Transplantation
Cord blood better than haploidentical mobilized PBL for sustained engraftment - Tissue Engineering
Fiber-based tissue engineered scaffold designed for ligament replacement - Tissue Engineering
Hydrogel scaffold developed for cell adhesion and neural outgrowth - Adult T-Cell Leukemia
TSLC1 overexpression may be a molecular marker for acute-type ATL - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
